BioSpace News Archive

Press Releases

Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion

September 26, 2025
·
5 min read
Press Releases

Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody

September 26, 2025
·
4 min read
Press Releases

FDA Grants HemoSonics 510(k) Clearance to Expand Use of Its Quantra Hemostasis System to Obstetric Procedures

September 26, 2025
·
4 min read
Press Releases

Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership

September 26, 2025
·
6 min read
Press Releases

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson’s Disease, Positioning for Strategic Pharma Partnerships

September 26, 2025
·
2 min read
Press Releases

Aspen Neuroscience Initiates Cohort 3 in ASPIRO Phase 1/2a Trial, Highlighting Commercial Formulation of ANPD001 and Its Transformative Potential for Parkinson’s Disease

September 26, 2025
·
4 min read
Press Releases

Lilly’s Ebglyss® for moderate-to-severe atopic dermatitis (eczema) listed on Quebec’s public drug formulary

September 26, 2025
·
6 min read
Press Releases

YouthBio Therapeutics Announces Positive FDA INTERACT Feedback for YB002, Establishing Clear Path to Clinic for First-in-Class Alzheimer’s Gene Therapy

September 26, 2025
·
2 min read
Press Releases

Arialys Therapeutics Receives FDA Rare Pediatric Disease Designation for ART5803 to Treat Anti-NMDA Receptor Encephalitis

September 26, 2025
·
4 min read
Press Releases

Intellia Therapeutics Announces Positive Longer-Term Phase 1 Data for Nexiguran Ziclumeran (nex-z) in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy

September 26, 2025
·
10 min read